Approval · Notice of Compliance 38436 · 2026
PMS-LOXAPINE: Notice of Compliance 38436
Issued October 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38436
- Date
- October 9, 2026
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-LOXAPINE | 02242868 | Marketed |
| PMS-LOXAPINE | 02230837 | Dormant |
| PMS-LOXAPINE | 02230838 | Marketed |
| PMS-LOXAPINE | 02230839 | Marketed |
| PMS-LOXAPINE | 02230840 | Dormant |
Medicinal ingredients
- LOXAPINE SUCCINATE 2.5 MG per TAB
- LOXAPINE SUCCINATE 5 MG per TAB
- LOXAPINE SUCCINATE 10 MG per TAB
- LOXAPINE SUCCINATE 25 MG per TAB
- LOXAPINE SUCCINATE 50 MG per TAB